Latest News and Press Releases
Want to stay updated on the latest news?
-
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a distribution agreement with the University of Zurich to...
-
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Hyperion™ Imaging System, significantly expanding the number...
-
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report third quarter 2017 financial results on Thursday, November 2,...
-
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue...
-
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer,...
-
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a...
-
SOUTH SAN FRANCISCO, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the sale of 9,090,909 shares of its common stock for aggregate gross proceeds of...
-
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the second quarter ended June 30, 2017. Total revenue for the...
-
加州南旧金山与中国中山市, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation(NASDAQ:FLDM)与 Ascendas Genomics 今日宣布建立战略合作,在中国开发分子诊断技术。 根据合作条款,Ascendas Genomics 将使用 Fluidigm® Biomark™ HD 和 Juno™...
-
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) announced today that its tax benefit preservation plan had expired pursuant to its terms,...